2.640USD-0.75%Mkt Cap: 6.50M $P/E: —1d ago
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
Indicators:|
Key Statistics
Company
Market Cap6.50M $
Enterprise Value-12.47M $
Revenue (TTM)77.88K $
Gross Profit6.83K $
Net Income (TTM)-7.23M $
Revenue/Share0.0770 USD
Last Price2.640 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.48
PEG—
EV/EBITDA1.50
EV/Revenue-160.06
P/S83.47
P/B0.33
EPS (TTM)-5.63
EPS (Forward)-5.47
52W Range
2.3403% of range12.03
52W High12.03 USD
52W Low2.340 USD
Profitability
Gross Margin9.02%
Oper. Margin-14129.33%
EBITDA Margin0.00%
Profit Margin-9551.87%
ROE-56.36%
ROA-52.91%
Growth
Revenue Growth11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M $
CapEx (TTM)203.90K $
FCF Margin-6288.08%
FCF Yield-75.34%
Net Debt-19.01M $
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity—
Current Ratio19.65
Quick Ratio19.32
Book Value/Sh8.039 USD
Cash/Share7.723 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMar 28, 2025
Analyst Consensus
Rating—
Target (Mean)7.500 USD
Upside (mean)+184.1%
Target Range7.500 USD – 7.500 USD
# Analysts1
Ownership
Shares Out.2.46M
Float2.20M
Insiders26.20%
Institutions4.35%
Short Interest
Short Ratio0.7d
Short % Float2.22%
Short % Out.2.22%
Shares Short54.62K
Short (prev mo.)180.13K
Technical
SMA 503.110 (-15.1%)
SMA 2004.531 (-41.7%)
Beta1.21
S&P 52W Chg20.25%
Avg Vol (30d)77.19K
Avg Vol (10d)34.11K
Technical Indicators
RSI (14)34.4
MACD-0.1333
MACD Signal-0.1040
MACD Hist.-0.0293
BB Upper3.295 USD
BB Middle2.944 USD
BB Lower2.594 USD
BB Width23.83%
ATR (14)0.1759 USD
Vol Ratio (20d)0.57x